Nordson Corp Dossier
Qualitative Analysis
Business overview
Nordson Corporation (NASDAQ: NDSN) is an American multinational corporation that designs, manufactures, and markets highly engineered products and systems used for the precision dispensing of adhesives, coatings, sealants, biomaterials, and other materials. Founded in 1954 and headquartered in Westlake, Ohio, the company operates direct sales and support offices in approximately 30 countries. Nordson's technology-based systems are also utilized in the testing and inspection of electronic components, surface treatment processes, and medical device component technologies. The company operates through three primary segments: Industrial Precision Solutions (IPS), Medical and Fluid Solutions (MFS), and Advanced Technology Solutions (ATS).
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
A multi-year strategic framework designed to deliver top-tier growth with leading margins and returns by focusing resources on high-growth, high-margin niches such as medical, fluid solutions, and advanced electronics.
Expected impact: Aims to drive annual sales toward $3 billion and achieve long-term EBITDA margins of 30% or higher.
Nordson's data-driven business system that utilizes 80/20 principles to prioritize and disproportionately invest in the top 20% of products and customers that generate the majority of revenues and profits.
Expected impact: Simplifies operations, improves operational throughput, shortens product cycles, and expands operating margins.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Provides an established and synergistic platform to grow Nordson's precision agriculture portfolio with mid-tier OEMs in North America, complementing the 2023 ARAG Group acquisition.
Financial impact: Contributed slightly to Industrial Precision Solutions segment sales in Q2 fiscal 2026; expected to drive incremental growth through cross-selling and North American market expansion.
Expands Nordson's medical technology portfolio into proprietary medical infusion fluid delivery and niche cardiovascular solutions, leveraging long-term secular growth trends.
Financial impact: Significantly bolstered the Medical and Fluid Solutions segment, introducing stable, recurring revenue streams from medical device OEMs.